Capital Finance
The decision is unrelated to the current COVID-19 coronavirus pandemic, Kaiser says.
Faster internet speeds, better tech and avoiding other potentially sick patients is pushing investors to pump money into the remote-care space.
Healthcare companies on Moody's list of lower-rated companies have about $41.6 billion of outstanding debt, a 28% increase in the past year.
The increasing size of healthcare deal values stemmed primarily from large buyouts, as the average deal size rose roughly 25%.
Interest rates remain at historic lows and purchase price multipliers will likely be attractive to purchasers.
Preventing the spread of infections could save as much as $41 million in healthcare costs and improve outcomes for those living with the virus.
The hospitals cited persistent health inequities in the region despite effort and investment from the State of Illinois and the local community.
The cost of ownership and repair of medical equipment, from infusion pumps to MRI machines, can be quite burdensome for the healthcare industry.
In 2018, total U.S. medical and health R&D investment was $194.2 billion. Of that, industry invested $129.5 billion, almost 67% of the total.
The latest round brings Bright Health's fundraising total to more than $1 billion.